EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS184-03642 
Organism
Homo sapiens 
Tissue/cell
T47D 
Coordinate
chr10:44360560-44361590 
TF binding sites/motifs
Number: 3             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
ZNF263MA0528.1chr10:44360965-44360986GCTTCTCCTCTGCCCTCCTCC-6.09
ZNF263MA0528.1chr10:44360977-44360998CCCTCCTCCTCTGTCTCCATC-6.2
ZNF263MA0528.1chr10:44360968-44360989TCTCCTCTGCCCTCCTCCTCT-6.34
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_46362chr10:44356915-44360683Osteoblasts
SE_55745chr10:44348191-44365593u87
SE_67551chr10:44348191-44365593u87
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr104436134144361425
Enhancer Sequence
TTTGACTTTT CTATACCCAT CTTCCTTATT GAAAAACAAG ATAGGAAACT TTTAGTTATT 60
AGCTAAATTA TGAAGACCTA ATAATGCATG GCATTATATC CTTGAAATTT GCTAATAGAT 120
TTCAAGTATT CTTATAAAAA TGTGATGGAT ATGGTGATTA GCTTGTTCCT GGTAATCTCA 180
CAATGCATAT ATCAAAACAT GACCTTGTAC ACCTTAAATA CTCAATTTTT ATTTGTTAGT 240
TATACTTCAA TAAAGCTCGG AAAACACACA CACGCATATT CACACACATA AAGAGTAGCA 300
GCCAAAACAG ATAACTGAAG AATTCCCTTG GCAGCCTGCG CTGAGCCCCG GGGCTGTTCG 360
TGCTCCCAGC CCTCTTTCTA TCCTCACATG GTGTGGTCCT GAGCTGCTTC TCCTCTGCCC 420
TCCTCCTCTG TCTCCATCCC TTTCCATTTG GCTCCTACTC CTACACACGA GTGGAAACTG 480
TGCACTCCAA ACCCAGGGGA CTGCAGGAAC CTTGTCCTGC ATCTCCCCCT AAACCCATGG 540
TGGGAACAGT CTCTCTGCCC TTCTCTGCAG GGGCTCCATT CCTCATCCAT CCTTTTCTCC 600
GTCTCTCCTG GTCACTCCTG CTGTCCACTG TCCTTTCCTC CTGGGCTCTG TGTTTCCACA 660
GCCCCTCTGT GCATTCCGCA CATGTCCTCT GAGTGGACTC TGCAGTCCCT GCCGGCCCCA 720
CACCGACTTG CCCTGTGTCC TGAGCACAGG TCTGCAGGTA ACAGTGACTG ATGGGTGTCT 780
CCACATTGTG ATATTCTGCT GGAACCTGAA ACAGCTGCCC TTGACAACAG CTCAGCACAG 840
AATCCCTGGC CATCCAGCTA TGACAGGGAC ATGGATCCTG CTTCTTCTTC CCGCCAGTCT 900
CTTAGTTGTC TATGCCTTCA CCCTGTAGTG GCCCATTCAG CCACTAAGTC CAGCTGCTCT 960
CCTTTCCGTG TCTGTGGAGT CACCCCTTAA TTCAGTTCCT GCGAGCTCAG TGGCCATGAT 1020
TTGATCATTC 1030